Ali-Jackson Kamil
SEC insider (Form 3/4/5 filer). CIK 0001654337. Director at RIGEL PHARMACEUTICALS INC (RIGL) and 1 other issuer. 6 reported Form 4/5 transactions since Sep 2024; latest on Jun 22, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Ali-Jackson Kamil has filed insider reports for
- RIGEL PHARMACEUTICALS INC (RIGL): Director
- PDS Biotechnology Corp (PDSB): Director
Ali-Jackson Kamil
CIK: 0001654337
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jun 22, 2026RIGL
RIGEL PHARMACEUTICALS INC
SaleDirect2.5K shares at avg. $35.00$88K - May 26, 2026RIGL
RIGEL PHARMACEUTICALS INC
SaleDirect2.5K shares at avg. $29.17$73K - May 15, 2026RIGL
RIGEL PHARMACEUTICALS INC
AwardDirect5.8K shares- - Jan 12, 2026PDSB
PDS Biotechnology Corp
AwardDirectEmployee Stock Option (Right to Buy)
54.9K shares- - Jun 11, 2025PDSB
PDS Biotechnology Corp
AwardDirectEmployee Stock Option (Right to Buy)
22.7K shares- - May 23, 2025RIGL
RIGEL PHARMACEUTICALS INC
AwardDirect2.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 22, 2026 |  RIGL RIGEL PHARMACEUTICALS INC | Sale | 2,500 | $35.00 | $87,500 | Direct |
| May 26, 2026 | RIGL RIGEL PHARMACEUTICALS INC | Sale | 2,500 | $29.17 | $72,925 | Direct |
| May 15, 2026 | RIGL RIGEL PHARMACEUTICALS INC | Award | 5,750 | - | $0 | Direct |
| Jan 12, 2026 |  PDSB PDS Biotechnology Corp | Award Employee Stock Option (Right to Buy) | 54,876 | - | - | Direct |
| Jun 11, 2025 | PDSB PDS Biotechnology Corp | Award Employee Stock Option (Right to Buy) | 22,700 | - | - | Direct |
| May 23, 2025 | RIGL RIGEL PHARMACEUTICALS INC | Award | 2,500 | - | - | Direct |
1-6 of 6 transactions